Women's Health Issues
Volume 15, Issue 1 , Pages 31-38 , January 2005

Understanding physicians’ attitudes towards hormone therapy

  • Rachel Hess, MD, MSc

      Affiliations

    • Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
    • Center for Health Equity Research and Promotion, VA Pittsburgh Health Care System, Pittsburgh, Pennsylvania
    • Corresponding Author InformationCorrespondence to: Rachel Hess, MD, MSc, 230 McKee Place, Suite 600, Pittsburgh, PA 15213.
    • ,
  • Chung Chou Joyce Chang, PhD

      Affiliations

    • Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Joseph Conigliaro, MD, MPH

      Affiliations

    • Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
    • Center for Health Equity Research and Promotion, VA Pittsburgh Health Care System, Pittsburgh, Pennsylvania
    • ,
  • Melissa McNeil, MD, MPH

      Affiliations

    • Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

Received 5 February 2004 ,Revised 20 April 2004 ,Accepted 1 October 2004.

References 

  1. Study of Osteoporotic Fractures Research Group Cauley JA , Seeley DG , Ensrud K , Ettinger B , Black D , Cummings SR . Estrogen replacement therapy and fractures in older women . Annals of Internal Medicine . 1995;122(1):9–16
  2. Collaborative Group on Hormonal Factors in Breast Cancer . Breast cancer and hormone replacement therapy (collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer) . Lancet . 1997;350(9084):1047–1059
  3. Davidson MH , Maki KC , Marx P , Maki AC , Cyrowski MS , Nanavati N , et al.   Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women . Archives of Internal Medicine . 2000;160(21):3315–3325
  4. Grady D , Wenger NK , Herrington D , Khan S , Furberg C , Hunninghake D , et al.   Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study . Annals of Internal Medicine . 2000;132(9):689–696
  5. Grodstein F , Manson JE , Colditz GA , Willett WC , Speizer FE , Stampfer MJ . A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease . Annals of Internal Medicine . 2000;133(12):933–941
  6. Grodstein F , Manson JE , Stampfer MJ . Postmenopausal hormone use and secondary prevention of coronary events in the nurses’ health study. a prospectiveobservational study . Annals of Internal Medicine . 2001;135(1):1–8
  7. Herrington DM , Reboussin DM , Brosnihan KB , Sharp PC , Shumaker SA , Snyder TE , et al.   Effects of estrogen replacement on the progression of coronary-artery atherosclerosis . New England Journal of Medicine . 2000;343(8):522–529
  8. Hersh AL , Stefanick ML , Stafford RS . National use of postmenopausal hormone therapy (annual trends and response to recent evidence) . Journal of the American Medical Association . 2004;291(1):47–53
  9. Hess R , Chang CC , Conigliaro J , Elnicki DM , McNeil M . Experiential learning influences residents knowledge about hormone replacement therapy . Teaching and Learning in Medicine . 2004;16(3):240–246
  10. Hodis HN , Mack WJ , Lobo RA , Shoupe D , Sevanian A , Mahrer PR , et al.   Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial . Annals of Internal Medicine . 2001;135(11):939–953
  11. Heart and Estrogen/progestin Replacement Study (HERS) Research Group Hulley S , Grady D , Bush T , Furberg C , Herrington D , Riggs B , et al.   Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women . Journal of the American Medical Association . 1998;280(7):605–613
  12. Jones MI , Greenfield SM , Bradley CP . Prescribing new drugs (qualitative study of influences on consultants and general practitioners) . British Medical Journal . 2001;323(7309):378–381
  13. McCormick BB , Tomlinson G , Brill-Edwards P , Detsky AS . Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior . Journal of the American Medical Association . 2001;286(16):1994–1999
  14. McNagny SE . Prescribing hormone replacement therapy for menopausal symptoms . Annals of Internal Medicine . 1999;131(8):605–616
  15. Mosca L , Collins P , Herrington DM , Mendelsohn ME , Pasternak RC , Robertson RM , et al.   Hormone replacement therapy and cardiovascular disease (a statement for healthcare professionals from the American Heart Association) . Circulation . 2001;104(4):499–503
  16. Newton KM , LaCroix AZ , Buist DS , Anderson LA , Delaney K . What factors account for hormone replacement therapy prescribing frequency? . Maturitas . 2001;39(1):1–10
  17. Nikolajevic-Sarunac J , Henry DA , O’Connell DL , Robertson J . Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy . Journal of General Internal Medicine . 1999;14(10):591–598
  18. Program Requirements for Residency Education in Internal Medicine . Chicago, IL: Accreditation Council for Graduate Medical Education; 2002;
  19. Rozenberg S , Fellemans C , Ham H . Opinion survey towards hormone replacement therapy in the prevention of coronary heart disease . Maturitas . 2001;38(3):273–277
  20. Schairer C , Lubin J , Troisi R , Sturgeon S , Brinton L , Hoover R . Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk . Journal of the American Medical Association . 2000;283(4):485–491
  21. Scuteri A , Bos AJ , Brant LJ , Talbot L , Lakatta EG , Fleg JL . Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women . Annals of Internal Medicine . 2001;135(4):229–238
  22. The North American Menopause Society . A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women (consensus opinion of The North American Menopause Society) . Menopause . 2000;7(2):76–86
  23. The Writing Group for the PEPI Trial . Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial . Journal of the American Medical Association . 1995;273(3):199–208
  24. The Writing Group for the PEPI Trial . Effects of hormone therapy on bone mineral density (results from the postmenopausal estrogen/progestin interventions (PEPI) trial) . Journal of the American Medical Association . 1996;276(17):1389–1396
  25. Torgerson DJ , Bell-Syer SE . Hormone replacement therapy and prevention of nonvertebral fractures (a meta-analysis of randomized trials) . Journal of the American Medical Association . 2001;285(22):2891–2897
  26. Women’s Health Initiative . Risks and benefits of estrogen plus progestin in healthy postmenopausal women (principal results From the Women’s Health Initiative randomized controlled trial) . Journal of the American Medical Association . 2002;288(3):321–333
  27. Viscoli CM , Brass LM , Kernan WN , Sarrel PM , Suissa S , Horwitz RI . A clinical trial of estrogen-replacement therapy after ischemic stroke . New England Journal of Medicine . 2001;345(17):1243–1249

PII: S1049-3867(04)00103-3

doi: 10.1016/j.whi.2004.10.002

Women's Health Issues
Volume 15, Issue 1 , Pages 31-38 , January 2005

Article Tools